Profile

20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for improved solubility of APIs and extended release. Validated as an eye drop, 20/20 OptimEyes has a successful lead pre-clinical program in glaucoma for which the company is seeking investment. It is also interested in partners with novel or repurposed APIs targeting mucosal areas for co-development opportunities.

20/20 OptimEyes Technologies Inc. logo
2020optimeyes.ca

Contact

Event details

Date: September 25 - 27, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

13 in total
  • 20/20 OptimEyes Technologies Inc.
    20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
  • CanaQuest
    CanaQuest is a clinical-stage life sciences company developing innovative cannabinoid-based therapeutics. Its…
  • Canurta Therapeutics
    Canurta stands at the forefront of biotechnological innovation, developing new small-molecule therapeutics from…
  • Healthyher.Life
    Healthyher.Life is a women’s health navigator platform for its member community of women and gender-diverse…
  • Hole Medical Ltd.
    Hole Medical Ltd. is a pioneering digital health aggregator at the forefront of healthcare innovation. Its…
  • ImmunoBiochem Corporation
    ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics…
  • Inertia
    For over two decades, Inertia has been the trusted partner for start-ups in the medical device, diagnostic, and…
  • JN Nova Pharma Inc.
    JN Nova Pharma is a Canadian biotech company collaborating with the National Research Council of…
  • Noa Therapeutics
    Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small…
  • ProteinQure Inc.
    ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
  • PurMinds NeuroPharma
    PurMinds is a neuro-medicine company pursuing breakthrough solutions to neurological disorders by leveraging…
  • QurCan Therapeutics Inc.
    QurCan Therapeutics is a biotechnology company that has developed the next-generation nanoparticle for safer and…
  • VeriLuce Therapeutics Inc.
    VeriLuce Therapeutics is an R&D/early-stage drug development company currently developing novel small…